ClinicalTrials.gg

Drug class

Serotonin and Noradrenaline Reuptake Inhibitors clinical trials

A class of medicines: the studies that test any of its 6 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
504
open now
35
in phase 3
159
first study started
1995

Keep track of what changes. Save the serotonin and noradrenaline reuptake inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Studies by the year they started

493 studies that test it; most in 2006 (36); 1 more planned to start later

Studies that test Serotonin and Noradrenaline Reuptake Inhibitors, by start year
YearStudies
19951
19963
19971
19993
20003
200113
200220
200314
200427
200524
200636
200730
200825
200935
201030
201135
201217
201313
201413
201512
201615
201715
201813
20196
202018
202121
202210
202310
202413
20259
20268

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
41
Phase 2
68
Phase 3
159
Phase 4
174
No phase
74

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 194 · Other 310

Eli Lilly and Company (90) · Wyeth is now a wholly owned subsidiary of Pfizer (34) · Forest Laboratories (17) · New York State Psychiatric Institute (13) · Pfizer (12) · Assiut University (8) · Rambam Health Care Campus (8) · Massachusetts General Hospital (7)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 504

See all 504 studies that test one of the serotonin and noradrenaline reuptake inhibitors →

Codes

What other systems call Serotonin and Noradrenaline Reuptake Inhibitors · ClinicalTrials.gg INT006539

  • MeSH (NLM) D000068760Serotonin and Noradrenaline Reuptake InhibitorsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.